Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Treatment with SR18662 significantly reduces growth and proliferation of CRC cells
FPH1 was suggested to be supplemented into the culture medium on day 1 and 5 at a concentration of 15-20 μM to induce functional proliferation of primary human hepatocytes in vitro
Epub 2015 May 17
Nafamostat Inhibits TNF-α-Induced Vascular Endothelial Cell Dysfunction by Inhibiting Reactive Oxygen Species Production
it is used for the treatment of rhinitis (e
JZL 184 - CAS# 1101854-58-3 oriconazole Treatment with SR18662 significantly reducesJZL184 is highly selective, and potent MAGL inhibitor ( monoacylglycerol lipase inhibitor). JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome. JZL184 attenuates LPS induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. JZL184 also suppresses inflammatory pain in the mouse carrageenan model. Product information CAS Number: 1101854 58 3 Molecular Weight:
US$ 343.50
US$ 277.20
US$ 150.00
US$ 498.50
US$ 420.00
US$ 164.00
US$ 160.50